London, UK, 21st July 2017 / Sciad Newswire / A survey of synthetic biology company start-ups in the UK is published today by
Life Science
Fri, 21/07/2017 - 07:30
Thu, 20/07/2017 - 10:59
Minomic International Ltd, an Australian immuno-oncology company, has initiated a prospective US trial of its MiCheck® prostate cancer screening test.
Wed, 12/07/2017 - 12:23
London, UK, 12th July 2017 / Sciad Newswire / SynbiCITE and Rainbow Seed Fund co
Thu, 29/06/2017 - 07:30
Australian immuno-oncology company Minomic International Ltd is proceeding to the second stage of its pioneering MILGa clinical trial of MiltuximabTM, a chimeric version of Minomic’s MIL-38 anti-Glypican1 antibody conjugated to the radioactive isotope 67Gallium.
Thu, 22/06/2017 - 07:00
First acquisition made by Invent Farma / neuraxpharm following the creation of the Group by funds advised by Apax Partners in August 2016
Mon, 12/06/2017 - 07:30
Coventry, UK, 12th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nov
Thu, 11/05/2017 - 14:15
London, UK, 11th May 2017 / Sciad Newswire / Two start-ups' proposals have been chosen as the winners of the first competition to discover and accelerate new synt
Mon, 24/04/2017 - 07:30
Phase 2a RSV Challenge Study Planned for Q3 2017
Wed, 19/04/2017 - 07:30
London, UK, 19th April 2017 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, is pleased to announce the appointment of Shawn O’Con
Mon, 10/04/2017 - 15:03
Nottingham, UK, 10th April 2017 / Sciad Newswire / Biocity Group (BioCity), the UK’s largest bioscience incubator, which t